Eyeworld

IMPORTANT SAFETY INFORMATION OMIDRIA must be added to irrigation solution prior to intraocular use. OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients. Systemic exposure of phenylephrine may cause elevations in blood pressure. Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other non-steroidal anti-infl ammatories (NSAIDs), or have a past medical history of asthma. The most commonly reported adverse reactions at 2-24% are eye irritation, posterior capsule opacifi cation, increased intraocular pressure, and anterior chamber infl ammation. Use of OMIDRIA in children has not been established. You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. INDICATIONS AND USAGE OMIDRIA is added to ophthalmic irrigation solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain. Please see the Full Prescribing Information for OMIDRIA at www.omidria.com/prescribinginformation. *Omeros will pay your facility, on behalf of your patient, the difference between your facility's acquisition cost for OMIDRIA and the amount covered by your patient's insurance, less a $30 patient responsibility. Reference: 1. OMIDRIA [package insert]. Seattle, WA: Omeros Corporation; 2015. OMEROS ® , OMIDRIA ® , and the OMIDRIA logo ® are registered trademarks, and OMIDRIAssure ™ is a trademark, of Omeros Corporation. © Omeros Corporation 2015, all rights reserved. 2015-241 Now you can provide the benefi ts of OMIDRIA— without worrying about coverage and reimbursement Assistance for fi nancially eligible uninsured or government-insured patients "EQUAL ACCESS" PATIENT ASSISTANCE PROGRAM Personalized help with reimbursement services related to OMIDRIA Assistance for patients with insuffi cient commercial insurance LIVE ASSISTANCE INFORMATION HOTLINE "WE PAY THE DIFFERENCE" COMMERCIAL REIMBURSEMENT PROGRAM* Because every patient deserves access to OMIDRIA... Enroll your next cataract surgery patient in OMIDRIAssure now! Talk to your Omeros Representative today or call 1-877-OMIDRIA (1-877-664-3742) to request a Patient Enrollment Form, or visit our online portal at www.OMIDRIAssure.com Introducing OMIDRIA ® (phenylephrine and ketorolac injection) 1% / 0.3% IS COVERED FOR MORE CATARACT SURGERY PATIENTS THAN YOU THINK Miosis prevention and post-op ocular pain reduction in one 1

• Cover
• _GoBack
• _GoBack (1)